A comprehensive view of Oral Medicines/Supplements. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Rise Therapeutics Announces FDA Clearance of its IND Application to Initiate a Phase 1 Study of an Oral Immunotherapy for the Treatment of Ulcerative Colitis
Published: January 31, 2023 by PR Newswire
Health Canada approves Apex Labs’ take home psilocybin clinical trial; study to evaluate efficacy, safety, tolerability of APEX-52, a microdose, oral synthetic psilocybin drug product to treat depression, anxiety in adults diagnosed with PTSD
Published: January 19, 2023 by Canada Newswire
Dr. Reddy's acquires trademark rights from Pfizer for Primcyv breast cancer drug as an oral capsule in India; Dr. Reddy's to manufacture Primcyv’s active pharmaceutical ingredient and finished drug at its FDA-approved state-of-the-art facilities
Published: January 16, 2023 by BioSpectrum India
Novo Nordisk announces FDA approval of label update for Rybelsus allowing use as a first-line option for adults with type 2 diabetes
Published: January 13, 2023 by ENP Newswire
Bristol-Myers Squibb Listed a New Clinical Trial to Study of Absorption, Metabolism, and Elimination of oral CC-90010 in Participants With Advanced Solid Tumors
Published: January 12, 2023 by Contify Life Science News

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count